表紙
市場調査レポート

心室補助装置の世界市場:2016〜2020年

Global Ventricular Assist Devices Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 239360
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
心室補助装置の世界市場:2016〜2020年 Global Ventricular Assist Devices Market 2016-2020
出版日: 2016年08月29日 ページ情報: 英文 93 Pages
概要

心室補助装置は心不全の治療に用いられます。弱くなった心臓が血液を他の臓器に送るのを助けるもので、急性または慢性の新機能の低下や心不全など重篤な心疾患の治療としてこの医療機器を埋め込みます。世界の心室補助装置市場は2016〜2020年にかけCAGR12.04%で拡大するとみられています。

当レポートでは、世界の心室補助装置市場について調査し、市場の製品別、用途別、エンドユーザー別、地域別動向、今後の成長見通しとともに、市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 心室補助装置の世界市場:製品別市場セグメンテーション

  • LVAD
  • BiVAD
  • RVAD

第7章 心室補助装置の世界市場:用途別市場セグメンテーション

  • BTT治療
  • BTD治療
  • ディスティネーション治療
  • BTR治療

第8章 心室補助装置の世界市場:エンドユーザー別市場セグメンテーション

  • 外来外科センター
  • 病院
  • 診療所

第9章 心室補助装置の世界市場:地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 心室補助装置の世界市場:促進因子

  • 心臓ドナーの不足と心臓移植のコストの高さ
  • 好ましい償還シナリオ
  • 心室補助装置の研究のCROへのアウトソーシング
  • 進行性の心不全のアンメットニーズへの注力

第11章 促進因子の影響

第12章 心室補助装置の世界市場:課題

  • 代替治療法
  • 製品リコール
  • 法規制の複雑さ
  • 合併症

第13章 促進因子と課題の影響

第14章 心室補助装置の世界市場:動向

第15章 ベンダー環境

  • 競合シナリオ
  • 市場シェア分析:2015年

第16章 主要ベンダー

  • ABIOMED
  • Berlin Heart
  • HeartWare
  • St. Jude Medical
  • その他の注目すべきベンダー

第17章 付録

第18章 Technavioについて

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR10032

About VADs

VADs are of three types - LVADs, BiVADs, and RVADs - that are used to treat heart failure. VADs help the weakened heart to pump blood for circulation to other body organs. Surgeons implant these mechanical devices as a treatment option for severe heart conditions such as acute or chronic cardiac functional deterioration and heart failure.

Technavio's analysts forecast the global ventricular assist devices (VADs) market to grow at a CAGR of 12.04% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global ventricular assist devices (VADs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different VADs. They are left ventricular assist devices, biventricular assist devices, and right ventricular assist devices.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Ventricular Assist Devices (VADs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ABIOMED
  • Berlin Heart
  • HeartWare
  • St. Jude Medical
  • Other prominent vendors
  • CardiacAssist Technologies
  • CORWAVE
  • EVAHEART
  • Jarvik Heart
  • Leviticus Cardio
  • ReliantHeart
  • Sunshine Heart
  • Ventracor

Market driver

  • Favorable reimbursement scenario
  • For a full, detailed list, view our report

Market challenge

  • Availability of alternative treatments
  • For a full, detailed list, view our report

Market trend

  • Focus on evidence-based research
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
  • You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global LVADs market
  • Global BiVADs market
  • Global RVADs market

PART 07: Market segmentation by application

  • BTT therapy
  • BTD therapy
  • Destination therapy
  • BTR therapy

PART 08: Market segmentation by end-user

  • ASCs
  • Hospitals
  • Physicians' offices

PART 09: Geographical segmentation

  • VADs market in Americas
  • VADs market in EMEA
  • VADs market in APAC

PART 10: Market drivers

  • Shortage of heart donors and high cost of heart transplantation
  • Favorable reimbursement scenario
  • Outsourcing research studies on VADs to CROs
  • Focus on unmet needs for advanced heart failure

PART 11: Impact of drivers

PART 12: Market challenges

  • Availability of alternative treatments
  • Product recalls
  • Regulatory complications
  • Complications associated with VADs

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Advances in technology
  • Market strategies used by small companies for market penetration
  • Increase in M&A
  • Focus on evidence-based research

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • PART 16: Major vendors
  • ABIOMED
  • Berlin Heart
  • HeartWare
  • St. Jude Medical
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Worldwide prevalence of heart failure 2015
  • Exhibit 03: VADs: Technological developments
  • Exhibit 04: Global VADs market
  • Exhibit 05: Market scenario of LVADs, BiVADs, and RVADs
  • Exhibit 06: LVADs: Significant clinical outcomes
  • Exhibit 07: Global VADs market 2015-2020 ($ billions)
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Global VADs market segmentation by product 2015
  • Exhibit 10: Global VADs market segmentation by product 2020
  • Exhibit 11: Global LVADs market: An overview
  • Exhibit 12: Global LVADs market 2015-2020 ($ billions)
  • Exhibit 13: Global LVADs market: Metrics analysis
  • Exhibit 14: Global BiVADs market: An overview
  • Exhibit 15: Global BiVADs market 2015-2020 ($ millions)
  • Exhibit 16: Global BiVADs market: Metrics analysis
  • Exhibit 17: Global RVADs market: An overview
  • Exhibit 18: Global RVADs market 2015-2020 ($ millions)
  • Exhibit 19: Global RVADs market: Metrics analysis
  • Exhibit 20: Global VAD market segmentation by application 2015
  • Exhibit 21: Overview of BTT therapy involving VADs
  • Exhibit 22: Overview of BTD therapy involving VADs
  • Exhibit 23: Overview of destination therapy involving VADs
  • Exhibit 24: Overview of BTR therapy involving VADs
  • Exhibit 25: Global VAD market segmentation by end-user 2015
  • Exhibit 26: Global VADs market segmentation by geography 2015 and 2020
  • Exhibit 27: Global VADs market segmentation by geography 2015-2020
  • Exhibit 28: Global VADs market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 29: VADs market in Americas: An overview
  • Exhibit 30: Hospital admission for congestive heart failure per 100,000 individuals in some countries in Americas 2008 and 2013
  • Exhibit 31: VADs market in Americas 2015-2020 ($ millions)
  • Exhibit 32: VADs market in Americas: Metrics analysis for various countries
  • Exhibit 33: VADs market in US: PEST analysis
  • Exhibit 34: Implements amended in ACA in US
  • Exhibit 35: Impact of ACO and ACA on VADs
  • Exhibit 36: VADs market in EMEA: An overview
  • Exhibit 37: Hospital admission for congestive heart failure per 100,000 individuals in few countries in EMEA 2008 and 2013
  • Exhibit 38: VADs market in EMEA 2015-2020 ($ millions)
  • Exhibit 39: VADs market in EMEA: Metrics analysis for various countries
  • Exhibit 40: VADs market in UK: PEST analysis
  • Exhibit 41: VAD market in APAC
  • Exhibit 42: Hospital admission for congestive heart failure per 100,000 individuals in few countries in APAC 2008 and 2013
  • Exhibit 43: VADs market in APAC 2015-2020 ($ millions)
  • Exhibit 44: VADs market in APAC: Metrics analysis for various countries
  • Exhibit 45: VADs market in Japan: PEST analysis
  • Exhibit 46: Estimated number of people in various countries awaiting heart transplantation 2014
  • Exhibit 47: Estimated reimbursement cost in various countries
  • Exhibit 48: CROs that helped companies receive regulatory approval for VADs
  • Exhibit 49: Impact of drivers
  • Exhibit 50: Product recalls: VADs
  • Exhibit 51: VADs under investigational use
  • Exhibit 52: Impact of drivers and challenges
  • Exhibit 53: Advanced products and their market impact
  • Exhibit 54: Market strategies and their impact
  • Exhibit 55: Acquisitions by some companies
  • Exhibit 56: Global VADs market: Competitive landscape analysis 2015
  • Exhibit 57: Global VADs market share analysis 2015
  • Exhibit 58: ABIOMED: Metrics analysis
  • Exhibit 59: Berlin Heart: Metrics analysis
  • Exhibit 60: HeartWare: Metrics analysis
  • Exhibit 61: St. Jude Medical: Metrics analysis
  • Exhibit 62: Other prominent vendors
Back to Top